AGR2 and pancreatic neoplasm: By enhancing endoplasmic reticulum folding capacity, AGR2 allows pre-cancerous cells to accommodate increased protein demand both before and after oncogenic mutations such as that of Kras, ultimately leading to pancreatic cancer progression [48].